These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20551298)

  • 21. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
    J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.
    Join-Lambert O; Coignard H; Jais JP; Guet-Revillet H; Poirée S; Fraitag S; Jullien V; Ribadeau-Dumas F; Thèze J; Le Guern AS; Behillil S; Leflèche A; Berche P; Consigny PH; Lortholary O; Nassif X; Nassif A
    Dermatology; 2011 Feb; 222(1):49-58. PubMed ID: 21109728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.
    Stass H; Rink AD; Delesen H; Kubitza D; Vestweber KH
    J Antimicrob Chemother; 2006 Sep; 58(3):693-6. PubMed ID: 16895940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
    Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
    Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty.
    Malincarne L; Ghebregzabher M; Moretti MV; Egidi AM; Canovari B; Tavolieri G; Francisci D; Cerulli G; Baldelli F
    J Antimicrob Chemother; 2006 May; 57(5):950-4. PubMed ID: 16551691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.
    van Nieuwkoop C; Visser LG; Groeneveld JH; Kuijper EJ
    J Infect; 2008 Feb; 56(2):155-6. PubMed ID: 18083235
    [No Abstract]   [Full Text] [Related]  

  • 27. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.
    O'Brien TP; Arshinoff SA; Mah FS
    J Cataract Refract Surg; 2007 Oct; 33(10):1790-800. PubMed ID: 17889778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations.
    Goudah A; Hasabelnaby S
    Chemotherapy; 2010; 56(1):26-31. PubMed ID: 20197659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of respiratory tract infections with moxifloxacin: results of postmarketing surveillance in China.
    Liu LY; Landen H
    Int J Clin Pract; 2007 Sep; 61(9):1509-15. PubMed ID: 17635617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract.
    Schwab D; Grauer M; Hahn EG; Mühldorfer S
    Aliment Pharmacol Ther; 2005 Sep; 22(5):417-22. PubMed ID: 16128679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.
    Simon N; Sampol E; Albanese J; Martin C; Arvis P; Urien S; Lacarelle B; Bruguerolle B
    Clin Pharmacol Ther; 2003 Oct; 74(4):353-63. PubMed ID: 14534522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cure of Q fever pneumonia with moxifloxacin: case report.
    Kuzman I; Puljiz I; Ethaković-Rode O
    Scand J Infect Dis; 2005; 37(10):778-80. PubMed ID: 16191902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
    Torkildsen G; O'Brien TP
    Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition kinetics of moxifloxacin in lactating ewes.
    Goudah A
    Vet J; 2008 Nov; 178(2):282-7. PubMed ID: 17900948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allometric scaling of marbofloxacin, moxifloxacin, danofloxacin and difloxacin pharmacokinetics: a retrospective analysis.
    Cox SK
    J Vet Pharmacol Ther; 2007 Oct; 30(5):381-6. PubMed ID: 17803728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration.
    Abd El-Aty AM; Goudah A; Shah SS; Shin HC; Shimoda M; Shim JH
    J Vet Pharmacol Ther; 2007 Dec; 30(6):586-91. PubMed ID: 17991229
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.
    Heystek M; Ross JD;
    Int J STD AIDS; 2009 Oct; 20(10):690-5. PubMed ID: 19815913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
    Signorovitch JE; Sheng Duh M; Sengupta A; Gu A; Grant R; Raut M; Mody SH; Schein J; Fisher AC; Ng D
    Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
    Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
    Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.